Managed Markets Network^®

Login

Cardiovascular

News

Semaglutide Approved for Cardiovascular Risk Reduction in Adults With T2D

Semaglutide Approved for Cardiovascular Risk Reduction in Adults With T2D

January 17, 2020

Understanding Diabetes Risks Can Save Your Limbs

December 03, 2019 –

Migraine Attack in Response to Nitroglycerin Showed Greater Cardiovascular Responses, Study Finds

November 15, 2019 – Alison Rodriguez

What We're Reading: Google, Ascension Plan Draws Scrutiny; Vascepa Goes Before FDA; Verma Defends Medicaid Changes

November 13, 2019 – AJMC Staff

Journals

2019 ADA Coverage: Renal Outcomes

June 30, 2019 – Mary Caffrey

CREDENCE: First Renal Outcomes Trial Finds Canagliflozin Cuts Risk of Renal Failure, Death; Prompts ADA Updates

June 29, 2019 – Mary Caffrey

Outcomes Trials Set Stage for Future of Diabetes Management in Patients With Renal Disease

June 29, 2019 – Joseph E. Cruz, PharmD, BCPS; and Mary Barna Bridgeman, PharmD, BCPS, BCGP

Conferences

Dr Danielle Kirkman Explains How Exercise Testing in Patients With CKD Can Improve Care

November 07, 2019

More CV, Renal Outcomes at ADA: CREDENCE, CARMELINA, CAROLINA

June 12, 2019 – Mary Caffrey

Highlighting Links Between Kidney, CV Disease in Diabetes

June 11, 2019 – Mary Caffrey

Multimedia

Dr John McMurray Explains the Heart Failure Benefits of Dapagliflozin in Patients With and Without Diabetes

Podcast: This Week in Managed Care—The $2 Million Gene Therapy and Other Health News

ACCOUNTABLE CARE DELIVERY CONGRESS

CONTINUING EDUCATION

Interactive Tools

Managed Care Podcast

Panel Discussions

Information for Reviewers

Information for Authors

Formulary Central

Clinical Study Summaries

Study Summaries

Terms & Conditions

Like Us On Facebook

Follow Us On Twitter

Check us out on LinkedIn

Follow us on Instagram

Subscribe us on YouTube

Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.